We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reviewers See No Bars to Approving Celltrion’s Biosimilar for Remicade
FDA Reviewers See No Bars to Approving Celltrion’s Biosimilar for Remicade
FDA reviewers have given their support to Celltrion’s proposed biosimilar for Remicade, finding no clinically meaningful differences between the copy and the original.